FOXO Technologies Inc (ID) (FOXOW)

Ask AI! Lol 

So what's next for this POS? A Reverse split and off to the OTC graveyard with its sister?

You mean like Rocket man
or The IRGC black robed leader with a Tunic.
Wow a Dictator that's is much worse than calling someone nasty
or they are as Dumb as a box of rocks.

Real companies would have fired him is accurate. Seamus actually got promoted! Lol He runs two companies with majority voting rights! It’s technically a dictatorship…

I think most of us are over it. You should stop wasting your time. Yes it's frustrating that Seamus has scammed us and continues to take a salary for sitting on the beach in the bahamas but that's the OTC for you. Real companies would have fired him a long time ago.

Another dud day…of waiting. Who else is tired of this? Another day RNVA is on the em with all my shares safe and FOXO is still no bid. Seriously ,who is feeling bullish with all these current situations? 

What an amazing accomplishment. Chapter one of the big turnaround. 🙄

Why was it pink limited to begin with.

And if I understood the date correctly in that video it seemed to really expand in 2011 that 3 years after leman bros collapse and the melt down in 2007-8

That’s all the same Shit
That Gensler has been involved with his entire life for the benefit of all us investors and in my opinion destroyed capitalism by letting the banks come in with the bank act including sabanes oxley and letting them totally control every stock exchange never been the same after about 1998

Jaytee
The problems at the SEC eclipse way beyond Anything at RNVA there is still nothing in the YouTube video. About shorting. Multiply reverse splits. Dollar rule on NYSE and Nasdaq or DTCC clearing rules or derivatives or Crypto spin offs

Seamus should resign.. wth does he have over all these people? Who in their right mind would give that dude controlling interests and majority voting rights? What’s the point of having members and shareholders? Maybe that’s the story Badazz is talking about. Seamus is resigning!!! Yayy!

Listening to the info
From the YouTube video and it appears to me it dates back to 2011 and the SEC has put us all through their bullshit rules for the last 15 years and now they have all the rules sorted out and the new tiers are all for our benefit while we have suffered for a decade and been wiped out by their big move by Gensler 4 years ago with reg 15c2-11

Hope nobody buys this after the next rs. Everyone knows that mass dilution will follow shortly after and we will be back at no bid.

We all know Seamus will hover around pink limited and pink current in order to execute next reverse split. This will not go em this year at least…

OTCID Today, emerged from pink limited

Gonna be a wonderful Thanksgiving when that 1 for 10,000 r/s hits… It’s already June folks. No clear light at the end of the tunnel for FOXO yet and RNVA is no closer to getting current. Everyday that passes only increases the bill to file. Man I wish Badazz would give us all a snippet of the good story he keeps referring to….. this is a travesty. The years are going by fast and ALL our safe shares are worth coals in Santa’s stockings

Your a moron

It's been over for three years now. When do they permanently delete this garbage ? What a waste of time 

FDA does not read posts, Scott… you know what they say about the word assume…

What do you mean what don’t I understand? That’s exactly what I have been saying.

these ceo and company have no intention of creating shareholder value for minority peon retail investors. .what don't you understand.? if the shares have any value. they keep the company for themselves via 99% share dilution scam etc and go private. and sell the company the public market for retail investors becoming a joke these days. it's just an ATM machine for insiders to sell shares. not to create shareholder value for a insiders and managment who own the company not for 'retail investors.

Retail traders like me are tired of being dumped on and left holding bags only to enrich incompetent ceos. In order for this to run we need a buyback , or some big news which is unlikely. A new ceo would help, they aren’t going to be able to pay his $500k salary much longer anyway.

You just might be right Scott. Usually well typically you see an influx of folks buying on such “awesome” news BUT seems folks are not falling for it this time. Seamus’s scheme might be over 

Yeah there's no appetite for this stock. one of the biggest disasters on the OTC.

That good news the other day sure has the volume pouring in!! Those few days of billions traded still might occur prior to reverse split. Good flip or two… stay tuned right Santa?

Badazz prefers to read Ho Man our time is near….ignore all the ill will cry babies here. It’s part of the great plan

Someone should file a class action lawsuit against all the pumpshits like jmoney360, lolo12, badshah, azart, filterthefartnoize, letgoofballroll, fatfinger punkerfarmah, mjam and several others for promoting obvious scams for their own benefit

Clever, clever, clever, clever boy...keep at it...

After years of promoting their in-house technology as the next major growth engine, management has essentially admitted operational failure with this fire sale.

A platform that pumpers claimed was worth millions has seen its exclusive, worldwide commercial rights signed away for a tiny 3% royalty capped at a meager $1.3 million. That lifetime cap does not even cover the company's $1.45 million net loss for a single quarter.

The technology is now functionally back in the hands of the original architect and patent inventor who successfully reclaimed his life's work for pennies. It is a massive professional victory for him, and a complete corporate surrender by current management.

FOXO still on paper owns the technology, but Sabes could develop some custom software application to try to sell to the big boys (companies) now that would exclude FOXO. When a major conglomerate decides to buy this technology, they won't buy it from a messy penny stock like FOXO. They will buy Jon Sabes' clean, private company and his custom application, because his firm holds the exclusive global commercial monopoly. Sabes pockets the massive acquisition windfall, while FOXO’s payout remains permanently frozen at that minor $1.3M lifetime royalty cap. FOXO keeps the paper title, but Sabes owns the bridge to the big companies.

After years of promoting their in-house technology as the next major growth engine, management has essentially admitted operational failure with this fire sale.

A platform that pumpers claimed was worth millions has seen its exclusive, worldwide commercial rights signed away for a tiny 3% royalty capped at a meager $1.3 million. That lifetime cap does not even cover the company's $1.45 million net loss for a single quarter.

The technology is now functionally back in the hands of the original architect and patent inventor who successfully reclaimed his life's work for pennies. It is a massive professional victory for him, and a complete corporate surrender by current management.

FOXO still on paper owns the technology, but Sabes could develop some custom software application to try to sell to the big boys (companies) now that would exclude FOXO. When a major conglomerate decides to buy this technology, they won't buy it from a messy penny stock like FOXO. They will buy Jon Sabes' clean, private company and his custom application, because his firm holds the exclusive global commercial monopoly. Sabes pockets the massive acquisition windfall, while FOXO’s payout remains permanently frozen at that minor $1.3M lifetime royalty cap. FOXO keeps the paper title, but Sabes owns the bridge to the big companies.

Before anyone tries to pump this 'strategic partnership' as positive, let’s look at the actual corporate history.

Jon R. Sabes is the founder and former CEO who was abruptly fired by this board in 2022, which triggered an official SEC investigation into the company in 2023.This isn't a brilliant new alliance; current management completely failed to commercialize the epigenetics technology on their own. Now that the company is nearly out of money, they had to crawl back to the very founder they ousted and hand over their core assets just to cut lab costs.

Giving away control of your primary technology to a former insider for a tiny 3% royalty cap doesn't change the active Going Concern warning or the 1-for-10,000 equity consolidation. The filings still show the same structural reality.

Idk goon. I was sure someone would spin the latest pr. Santa and elves are definitely not bullish. They won’t ever admit though. Honestly, I would like to hear from Jmoney and lolo12! lol Santa and friends are boring as fk! He instructs everyone to ignore logical negative reasoning….

Remember the good ole days when forward looking prs would move pinks at least two ticks up? 

Chugai Pharma could have easily picked up this and commercialized it. Why didn’t they? Why did the great Seamus squander that opportunity And chose to “spin-off” the tech? Or maybe because Chugai, a multi billion dollar company, decided it wasn’t worth it. Explain how the inventor of the tech and former ceo allowed this awesome ai to become outdated in the 1st place? Yep it’s a Hail Mary shot! 

Juvenile response. But yeah that's expected from you. Anyway,it's called due diligence and research. Most people conduct that BEFORE investing. All pr's should be analyzed and dissected and not just taken at face value. If you can't see that this is just another hail mary, then sign up for 5th grade summer learning. I could make it happen. How about you start with a little Google search about the epigenetics AI sector. Might clarify some of your misunderstandings. Remember Google is your friend.

One of these days you need to post a pic of your classroom and the 2 by 4 you live in😀😀😀FOXO is going to clean you out…

Great fluff news...sorry guys but I've said this a long time ago. FOXO is too late to the game. The market has been cornered and commercialized by tons of other companies utilizing similar or improved tech. It is what it is GL

Ho man. Bring the noise

Finally something positive

FOXO TECHNOLOGIES, INC., FORMS STRATEGIC PARTNERSHIP WITH LONGEVITYFP TECHNOLOGIES, LLC. TO COMMERCIALIZE FOXO’S EPIGENETICS TECHNOLOGY

WEST PALM BEACH, FL and MINNETONKA, MN, May 28, 2026 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (OTC: FOXO) (the “Company”) and LongevityFP Technologies, LLC. (“LFP”) today jointly announced a strategic partnership to commercialize the Company’s pioneering epigenetics technology. The partnership is in the form of an exclusive license agreement (the “Agreement”) whereby the Company’s epigenetics-related technology including the Company’s two patents and related intellectual property, will be licensed to LFP.

LongevityFP Technologies, LLC., is owned and operated by Jon R. Sabes, the named inventor on the platform’s core patents and the original architect of the Company’s epigenetics underwriting platform. Jon is the founder of FOXO’s predecessor entity, and served as the Company’s chief executive officer through 2022.

In connection with the Agreement, LFP will pay FOXO a royalty of three percent (3%) of LFP’s net revenues, subject to an aggregate cap of $1.3 million. In addition, LFP has been granted an option, exercisable within ten (10) years, to acquire majority ownership of the Company’s subsidiary, FOXO Labs, Inc. (“FOXO Labs”). FOXO Labs owns substantially all of the Company’s epigenetics-related intellectual property, including the Company’s two issued patents, pending applications, proprietary datasets and models, and related intellectual property. The option if exercised, will provide FOXO with a 40% equity interest in the resulting epigenetics enterprise, as defined in the Agreement. The agreement resolves all prior matters between the parties and creates an opportunity to commercialize the technology and create value.

Mr. Sabes has expertise in modernizing the archaic underwriting process used by the life insurance industry, which still requires blood and urine specimen collection for the sale of its permanent life insurance products. He believes the epigenetics technology can replace the existing high-volume invasive diagnostics with a modern non-invasive alternative.

FOXO Benefits

Revitalized effort to commercialize its epigenetic technology
Royalty stream from LFP
Upside through a 40% equity interest in the resulting epigenetics enterprise
Allows FOXO senior management to focus on its core healthcare services operations

LFP Benefits

Reunion of the technology platform with its inventor and original architect
Commercialization with advanced AI and recent research validating the predictive power of epigenetic biomarkers
Exclusive, worldwide, rights to commercialize a validated and patented epigenetics technology
Renewed commercial opportunity driven by advances in artificial intelligences

Seamus Lagan, Chief Executive Officer of FOXO, explained, “We are excited to join forces with former FOXO CEO, Jon Sabes. FOXO’s epigenetics technology has not been commercialized over the last few years under the FOXO Technologies Inc. corporate structure. By entering into this agreement with Sabes the technology is being reunited with its visionary and founder, creating a practical pathway to unlock value from the technology while materially improving the Company’s financial and strategic position.”

“I am thrilled to be reunited with this pioneering technology, on which I am the named inventor and co-creator on U.S. Patent Nos. 11,795,495 and 11,817,214. Recent advances in artificial intelligence, combined with newly published research demonstrating the predictive power of epigenetic DNA methylation patterns as biomarkers of biological aging, have strengthened the original business case on which FOXO was founded. I am grateful for the opportunity and committed to working diligently to create value for FOXO and its stockholders.” stated Jon R. Sabes, Managing Member of LongevityFP Technologies, LLC.

About FOXO Technologies Inc. (“FOXO”)

FOXO owns and operates four key subsidiaries.

Rennova Community Health, Inc., owns and operates Scott County Community Hospital, Inc. (d/b/a Big South Fork Medical Center), a critical access designated (CAH) hospital in East Tennessee.

Myrtle Recovery Centers, Inc., a 30-bed behavioral health facility in East Tennessee. Myrtle provides inpatient services for medically supervised withdrawal treatment and residential treatment and outpatient services for MAT and OBOT programs.

Vector BioSource, Inc. is an information, data and biospecimen sourcing provider serving the biotechnology, clinical research and pharmaceutical research industries.

FOXO Labs, Inc. is a biotechnology company dedicated to improving human health and life span through the development of cutting-edge technology and product solutions for various industries.

For more information about FOXO, visit www.foxotechnologies.com. The Company will file a Current Report on Form 8-K with the Securities and Exchange Commission containing additional information about the partnership and the strategic technology license agreement.

About LongevityFP Technologies, LLC (“LFP”)

LongevityFP Technologies, LLC was formed to commercialize advanced epigenetic underwriting technology for the life insurance industry. Jon R. Sabes serves as Chief Executive Officer.

Forward-Looking Statements

This press release is jointly issued by FOXO Technologies Inc. and LongevityFP Technologies, LLC, and contains forward-looking statements made by, or attributable to, each of them. Forward-looking statements include those that use words such as “expects,” “anticipates,” “believes,” “intends,” “plans,” “projects,” “estimates,” “may,” “will,” “should,” “could,” or similar expressions. These statements are not historical facts, including statements about FOXO’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties, and a number of factors could cause actual results to differ materially from those contained in any forward-looking statement. These factors include, but are not limited to the risk of changes in the competitive and highly regulated industries in which FOXO operates; variations in operating performance across competitors or changes in laws and regulations affecting FOXO’s business; the ability to implement FOXO’s business plans, forecasts, and other expectations; the ability to obtain financing; the risk that FOXO has a history of losses and may not achieve or maintain profitability in the future; the enforceability of FOXO’s intellectual property, including its patents and the potential infringement on the intellectual property rights of others; and the risk of downturns and a changing regulatory landscape in the highly competitive industries in which FOXO operates. The foregoing list of factors is not exhaustive. Readers should carefully consider the foregoing factors and the other risks and uncertainties discussed in FOXO’s most recent reports on Forms 10-K and 10-Q, particularly the “Risk Factors” sections of those reports, and in other documents FOXO has filed, or will file, with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and FOXO assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.

Contact:

FOXO Technologies Inc.
Sebastien Sainsbury
ssainsbury@foxotechnologies.com
(561) 485-0151

LongevityFP Technologies, LLC
LongevityFP Technologies, LLC
Jon Sabes
jsabes@longevityfp.com
(612) 388-2223
https://www.globenewswire.com/newsroom/ti?nf=OTcyNzk5MCM3NjI1MzkwIzUwMDEyOTAzMQ==
https://ml.globenewswire.com/media/MzA2OGE0MzItYWM2NC00NjVhLTlkN2UtNGI1ZDRkN2VkZjYzLTUwMDEyOTAzMS0yMDI2LTA1LTI4LWVu/tiny/FOXO-Technologies-Inc-.png

Source: FOXO Technologies Inc.

© 2026 GlobeNewswire, Inc.

Foxco Technologies is forming a strategic partnership with Longevity FB Technologies to commercialize the company's epigenetics technology.

Conduct some due diligence. You will answer your own questions. At the end of the day,  Let’s all hope to recoup our investments. If we get a little more out of  this travesty, then that’s lagniappe… good luck to us all 

If they get access to the $5M...is the feeling that, that will be used for expenses to cover quarterly losses? OR Do they use it for investment into Vector which they were supposed to invest $1m there or maybe other acquisitions? I mean how in the world do they expect to pay the $7m next yr? 
ImhoMj

Otcid fka pink current. It’s the same stinky pinky status. Only upgrade is a name change..

Upgraded to OTCID

They couid have got an asset based loan but that would require Seamus to do some work to ensure the business generates enough profit to pay it back. It’s easier to sit on the beach in the Bahamas and print shares - imo.

Uplisted….. Take all that free cash flow they spent to pay back late taxes and buyback shares that’s just one way to utilize “free cash flow” but hey let’s stick to trust the da process. Seamus knows what he’s doing! Seamus has proven only one thing he is the smartest inept ceo of all time. Broke laws, ran two companies into the ground and is a millionaire. Wow!

Nope RNVA dealing with legal shit that’s why he moved assets to FOXO. A 5 minute due diligence on FOXO would have told you they were over valued. You know what would have made more sense? Uplist RNVA ummm duh! There was no need to even go the FOXO route. There are many ways Seamus could have gotten RNVA unlisted… No illegal naked shorts here…